Jonathan Moss to Analgesics, Opioid
This is a "connection" page, showing publications Jonathan Moss has written about Analgesics, Opioid.
Connection Strength
1.828
-
Identifying and Treating Opioid Side Effects: The Development of Methylnaltrexone. Anesthesiology. 2019 01; 130(1):142-148.
Score: 0.468
-
Methylnaltrexone (Relistor®) does not impact opioid-mediated analgesia at therapeutic doses. Pain. 2014 Dec; 155(12):2722.
Score: 0.346
-
Effect of perioperative opioids on cancer recurrence: a hypothesis. Future Oncol. 2010 Aug; 6(8):1237-42.
Score: 0.261
-
Subcutaneous methylnaltrexone to restore postoperative bowel function in a long-term opiate user. Int J Gynecol Cancer. 2010 Feb; 20(2):308-10.
Score: 0.252
-
Reversal of opioid-induced gastric dysfunction in a critically ill burn patient after methylnaltrexone. Anesth Analg. 2008 Dec; 107(6):1965-7.
Score: 0.233
-
Treatment with methylnaltrexone is associated with increased survival in patients with advanced cancer. Ann Oncol. 2016 11; 27(11):2032-2038.
Score: 0.099
-
The Mu opioid receptor promotes opioid and growth factor-induced proliferation, migration and Epithelial Mesenchymal Transition (EMT) in human lung cancer. PLoS One. 2014; 9(3):e91577.
Score: 0.084
-
Pseudomonas aeruginosa virulence expression is directly activated by morphine and is capable of causing lethal gut-derived sepsis in mice during chronic morphine administration. Ann Surg. 2012 Feb; 255(2):386-93.
Score: 0.072
-
Attenuation of vascular permeability by methylnaltrexone: role of mOP-R and S1P3 transactivation. Am J Respir Cell Mol Biol. 2007 Aug; 37(2):222-31.
Score: 0.013